Latest Updates


BPSA Releases Guide to Production of Cell and Gene Therapies

ARLINGTON, VA – The Bio-Process Systems Alliance, the primary international industry association for single-use bio-processing, is pleased to announce the release of its latest white paper, The Role of Single-Use Polymeric Solutions in Enabling Cell and Gene Therapy Production, compiled by a select committee of experts in the fields of single-use technology (SUT) and cell and gene therapies.

February 25, 2019

Edgewater Capital Partners Closes Fund IV at $185 Million Hard Cap

Cleveland, OH, February 18, 2019 – Edgewater Capital Partners (“Edgewater”) is pleased to announce the closing of Edgewater Capital Partners IV LP (“ECP IV”), a size and sector focused buyout fund dedicated to investing in middle and lower middle-market performance materials businesses. ECP IV, with $185 million in capital commitments, had a first and final closing at its hard cap and above its initial target.

February 22, 2019

TSCA Section 5 Extensions Issued Post-Shutdown

EPA has published a Federal Register Notice stating that it is extending the review periods for all TSCA Section 5 PMNs, SNUNs, MCANs, and exemption notices that were submitted to the Agency under TSCA section 5 before December 29, 2018 and for which the review period of those notices had not yet expired as of that date. This extension impacts 581 new chemical notifications.

February 5, 2019




TSCA Delays Anticipated Due to Government Shutdown

With the U.S. government shutdown moving into its third week, the Environmental Protection Agency (EPA) has signaled it anticipates delays related to its responsibilities under the Toxic Substances Control Act (TSCA).

January 9, 2019


SOCMA Announces 2018 Performance Improvement Award Winners

ARLINGTON, VA – The Society of Chemical Manufacturers and Affiliates (SOCMA) is pleased to announce that more than 40 SOCMA member facilities will receive 2018 Performance Improvement Awards for their commitment to continuously improving environmental, health, safety and security (EHS&S) practices at the association’s 97th Annual Dinner, December 10, in New York.

November 18, 2018

John DiLoreto to Discuss Manufacturing & Supply Chain Challenges at FDA Summit

ARLINGTON, VA – John DiLoreto, Executive Director of the Bulk Pharmaceuticals Task Forceand advisor to SOCMA’s PharmaChem Sector, will participate in a panel discussion about Manufacturing and Supply Challenges at a U.S. Food & Drug Administration event sponsored by Duke Margolis Center for Health Policy.

November 16, 2018